tiprankstipranks
Trending News
More News >
Provectus Pharmaceuticals (PVCT)
OTHER OTC:PVCT
US Market

Provectus Pharmaceuticals (PVCT) Revenue

Compare
79 Followers

Provectus Pharmaceuticals Revenue

Provectus Pharmaceuticals had a revenue of 0.00 in the quarter ending Mar 31, 2025, with -100.00%. This bring the company's revenue in the last twelve months to 269.32K, Increased -46.92%. In the fiscal year ending Dec 31, 2024, Provectus Pharmaceuticals had annual revenue of 617.14K with 10.66% growth.
Revenue (ttm)
269.32K
Revenue Growth
P/S Ratio
53.94
Revenue/Employee
$102,857
Employees
6
Market Cap
$33.29M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
617.14K59.43K+10.66%
Dec 31, 2023
557.71K-431.33K-43.61%
Dec 31, 2022
989.04K+∞%
Dec 31, 2021
0.00
Dec 31, 2020
0.00
Dec 31, 2019
0.00
Dec 31, 2018
0.00
Dec 31, 2017
0.00
Dec 31, 2016
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis